Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 2;17(1):170-190.
doi: 10.1080/20523211.2023.2291508. eCollection 2024.

Clinical pharmacists' interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis

Ola Yakti  1 , Daoud Al-Badriyeh  2 , Mohammed Rijims  3 , Mohammed Abdelaal  4 , Omar Alsoukhni  5 , Moza Al Hail  3 , Palli Valapila Abdulrouf  3 , Wessam El-Kassem  3 , Fouad Abounahia  6 , Rasha Kaddoura  7 , Dina Abushanab  3
Affiliations

Clinical pharmacists' interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis

Ola Yakti et al. J Pharm Policy Pract. .

Abstract

Objective: This study aimed to assess the overall economic impact of clinical pharmacist interventions in the neonatal ICU (NICU) in Qatar.

Methods: A retrospective review of neonates' records was performed over a 3-month duration in the NICU of Qatar to determine the total economic benefit of clinical pharmacist interventions. The total benefit of interventions was calculated by considering the cost avoidance due to preventable adverse drug events (ADEs) and the cost savings associated with the revised resource use due to interventions. Sensitivity analyses were conducted to ensure the robustness and generalizability of the results.

Results: A total of 513 interventions were analyzed, involving 150 neonates. Most of the drug-related problems were related to therapy dosing, followed by drug choice appropriateness, the addition of prophylactic treatment, and administration frequency. The overall annual benefit was estimated at QAR 4,178,352 (1,147,584), which consisted of cost avoidance of QAR 1,050,680 (USD 288,648) and an overall cost saving of QAR -6091 (USD -1673).

Conclusions: While the clinical pharmacist interventions led to increased resource utilisation and associated costs, when considering the avoided costs of ADEs, the overall clinical pharmacist practices in the NICU setting were economically beneficial.

Keywords: Adverse drug event; Neonates; cost savings; economics; intervention; pharmacist.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Total benefit probability curve over a 3-month period (one-way sensitivity analysis).
Figure 2.
Figure 2.
Total benefit probability curve over a 1-year period (one-way sensitivity analysis).
Figure 3.
Figure 3.
Total benefit probability curve over a 3-month period (probabilistic sensitivity analysis).
Figure 4.
Figure 4.
Total benefit probability curve over a 1-year period (probabilistic sensitivity analysis).
Figure 5.
Figure 5.
A regression tornado diagram of elements and their effect on the outcome.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Abushanab, D., Atchan, M., Elajez, R., Elshafei, M., Abdelbari, A., Al Hail, M., Abdulrouf, P. V., El-Kassem, W., Ademi, Z., Fadul, A., Abdalla, E., Diab, M. I., & Al-Badriyeh, D. (2023). Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar. PLoS One, 18(6), e0286419. 10.1371/journal.pone.0286419 - DOI - PMC - PubMed
    1. Abushanab, D., Gulied, A., Hamad, A., Abu-Tineh, M., Abdul Rouf, P. V., Al Hail, M., El-Kassem, W., El Hajj, M. S., & Al-Badriyeh, D. (2023). Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital. Journal of Oncology Pharmacy Practice, 29. 10.1177/10781552231160275 - DOI - PubMed
    1. Abushanab, D., Rouf, P. A., Al Hail, M., Kamal, R., Viswanathan, B., Parappil, H., Elkassem, W., Al-Shaibi, S., & Al-Badriyeh, D. J. C. T. (2021). Cost-effectiveness of oral versus intravenous Ibuprofen therapy in preterm infants with patent ductus arteriosus in the neonatal intensive care setting: A cohort-based study. Clinical Therapeutics, 43(2), 336–348. e337. - PubMed
    1. Al-Badriyeh, D., Kaddoura, R., AlMaraghi, F., Homosy, A., Hail, M. A., El-Kassem, W., Rouf, P. V. A., Fadul, A., Mahfouz, A., Alyafei, S. A., & Abushanab, D. (2023). Impact of clinical pharmacist interventions on economic outcomes in a cardiology setting in Qatar. Current Problems in Cardiology, 48(9), 101838. 10.1016/j.cpcardiol.2023.101838 - DOI - PubMed
    1. Arredondo, E., Udeani, G., Horseman, M., Hintze, T. D., & Surani, S. (2021). Role of clinical pharmacists in intensive care units. Cureus, 13(9), e17929. 10.7759/cureus.17929 - DOI - PMC - PubMed

LinkOut - more resources